tirofiban has been researched along with Cardio-embolic Stroke in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, L; Guo, Z; Jiang, J; Li, F; Long, T; Luo, Y; Lv, Z; Meng, R; Qiu, Z; Rong, B; Tian, J; Xie, Y; Yang, Y; Yuan, Z; Zeng, H; Zhang, S; Zhao, J; Zi, W | 1 |
| Chen, J; Duan, J; Ji, X; Li, C; Li, S; Liu, G; Ma, Q; Ren, C; Song, H; Wang, R; Wu, C; Wu, L; Xu, J; Zhao, W | 1 |
1 trial(s) available for tirofiban and Cardio-embolic Stroke
| Article | Year |
|---|---|
Association of tirofiban treatment with outcomes following endovascular therapy in cardioembolic stroke: insights from the RESCUE BT randomized trial.
Topics: Brain Ischemia; Embolic Stroke; Endovascular Procedures; Humans; Intracranial Hemorrhages; Stroke; Tirofiban; Treatment Outcome | 2023 |
1 other study(ies) available for tirofiban and Cardio-embolic Stroke
| Article | Year |
|---|---|
Low-dose tirofiban is associated with reduced in-hospital mortality in cardioembolic stroke patients treated with endovascular thrombectomy.
Topics: Brain Ischemia; Embolic Stroke; Endovascular Procedures; Fibrinolytic Agents; Hospital Mortality; Humans; Stroke; Thrombectomy; Tirofiban; Treatment Outcome | 2021 |